Effect of p53 polymorphism on the susceptibility of cervical cancer

Gynecologic and Obstetric Investigation

Volumn 51, Issue 3, 2001, Pages 197-201

  Yang, Yuh Cheng ^a   Chang, Chih Long ^a   Chen, Mong Liang ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Adenocarcinoma; Cervical cancer; p53 Polymorphism

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ALLELE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; HOST SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PAPILLOMAVIRIDAE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0035044988     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052924     Document Type: Article

References (30)

1. Database of p53 gene somatic mutations in human tumors and cell lines
2. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
3. The role of HPV in the etiology of cervical cancer
4. HPV and p53 in cervical cancer
5. Risk factors for cervical cancer by histology
6. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
7. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
8. Molecular biology of cervical cancer and its precursors
9. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells
10. HLA control in the progression of human papillomavirus infection
11. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
12. p53 codon 72 polymorphism and risk of cervical cancer in UK
13. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection
14. p53 polymorphism and risk of cervical cancer
15. p53 polymorphism and risk of cervical cancer
16. p53 polymorphism and risk of cervical cancer
17. No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer
18. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers
19. Primary structure polymorphism at amino acid residue 72 of human p53
20. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small-cell lung cancer patients
21. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients: Discrete results with smoking history
22. p53 polymorphism in ovarian and bladder cancer
23. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer
24. p53 polymorphism in ovarian and breast cancer
25. Two polymorphic variants of wild-type p53 differ biochemically and biologically
26. p53 polymorphisms and haplotypes in different ethnic groups
27. Squamous and adenocarcinoma of the uterine cervix: A comparison using routine data
28. Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix
29. Molecular characterization of adenocarcinoma of the cervix
30. HLA class II antigen expression in human papillomavirus-associated cervical cancer